NON SMALL CELL LUNG
Clinical trials for NON SMALL CELL LUNG explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug EPI-326 enters first human trials for tough cancers
Disease control Recruiting nowThis early-stage study tests a new drug called EPI-326 in about 110 people with advanced lung cancer (with a specific EGFR mutation) or head and neck cancer. The main goal is to check safety and find the best dose. Researchers will also see if the drug helps shrink tumors.
Matched conditions: NON SMALL CELL LUNG
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated May 17, 2026 06:58 UTC
-
New pfizer drug shows promise in early cancer trial
Disease control Recruiting nowThis early-stage study tests a new medicine, PF-08046033, in adults with advanced lung, esophageal, or skin cancer that has spread or can't be removed. The main goals are to check safety, find the right dose, and see if it helps control the cancer. Participants receive the drug i…
Matched conditions: NON SMALL CELL LUNG
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 17, 2026 06:49 UTC
-
Smart CAR t cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment called A2B395 for adults with advanced solid tumors (like colorectal, lung, breast, and kidney cancers) that have not responded to standard therapy. The treatment uses specially engineered immune cells designed to kill cancer cells while protectin…
Matched conditions: NON SMALL CELL LUNG
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC